pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Therapeutic Nuclear Medicines Market Report 2017


Published On : Mar 2017

Category : Therapeutic Area

No. of Pages : 105 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  

In this report, the EMEA Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume (MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Therapeutic Nuclear Medicines for each application, including
Hospitals
Ambulatory Surgical Centers
Other
 

The industry of therapeutic areas refers to particular segments in the healthcare sectors for conditions and diseases, within which lie known medical treatments or highly potential treatments currently in a phase of development. Therapeutic area analysis helps classify treatments and drugs based on the diseases and conditions that they are used for, rather than other factors that are essential from a purely business of medical administration point of view.

For the Emea europe middle east and africa therapeutic nuclear medicines market report 2017, this research report can be a foothold towards various opportunities as well as the method to find solutions to unique challenges exist in this market. The report additionally provides a chance for users to comprehending the various trends in the market and its dynamics at all levels. The approach that analysts have made to compile this report is based primarily on precision; it has enabled the research team to create a valuable document on the market with as many details as possible. The report offers an insightful SWOT analysis, along with the Porter’s Five Forces analysis to represent the core dynamics of the market. Additional analytics offered in the report pertain to its economic, social, technological, political, and environmental aspects.

The report uses various proven market research and measurement tools that provide the user a detailed examination of the Emea europe middle east and africa therapeutic nuclear medicines market report 2017 and help them make informed investment and business decisions. The detailed format of the report gives a market perspective on a macroscopic as well as microscopic scale. It collates primary and secondary research methodologies in order to do so. The report also provides an analysis of the regulatory framework associated to the market and through it, provides details regarding their impact on the market’s growth rates in various segments. The segmentation provided in the research report on the basis of region, product, application, and service allows the readers to understand the specific drivers and restraints.

The geographical analysis of the Emea europe middle east and africa therapeutic nuclear medicines market report 2017 can be valuable for those choosing to venture out into new regions or even for those who want to gauge the viability of new personal care products and services in their current region or regions of operation. A further level of clarity can be achieved by imbibing the analysis the report provides on the competitive landscape of the market. This section involves the complete analysis of key players in the market and what this report’s users can do to rise up to the challenge of business expansion.

Specialists have made a point by point evaluation out of the Emea europe middle east and africa therapeutic nuclear medicines market report 2017 and its competitive landscape, combined with refreshed profile audits of the main organizations up until now, to give the clients of this report with a thorough enumeration on the market’s pioneers. The aggressive investigation includes a subjective connection between the different parameters affecting the Emea europe middle east and africa therapeutic nuclear medicines market report 2017 and the part of the main players in the market over the coming years. These elements of investigation likewise incorporate focuses from the income created by each key player, their exceptional offering suggestions, and the center methodologies embraced by them as far as item improvement or provincial development.

List of Tables and Figures

Figure Product Picture of Therapeutic Nuclear Medicines
Figure EMEA Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture
Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture
Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture
Figure EMEA Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Other Examples
Figure EMEA Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Players (2012-2017)
Figure 2016 Therapeutic Nuclear Medicines Sales Share by Players
Figure 2017 Therapeutic Nuclear Medicines Sales Share by Players
Figure EMEA Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) by Players (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue Share by Players (2012-2017)
Table 2016 EMEA Therapeutic Nuclear Medicines Revenue Share by Players
Table 2017 EMEA Therapeutic Nuclear Medicines Revenue Share by Players
Table EMEA Therapeutic Nuclear Medicines Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2016
Table EMEA Therapeutic Nuclear Medicines Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Application (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Application (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share by Application in 2016
Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share in 2016
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Revenue Market Share Regions in 2016
Table EMEA Therapeutic Nuclear Medicines Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Market Share by Type (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Market Share by Type in 2016
Table Europe Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017)
Table Europe Therapeutic Nuclear Medicines Market Share by Application (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Market Share by Application in 2016
Table Europe Therapeutic Nuclear Medicines Sales (MT) by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries in 2016
Table Europe Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016
Figure Germany Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure France Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure UK Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Russia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Italy Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Market Share by Type (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Market Share by Type (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Sales (MT) by Applications (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Market Share by Applications (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Sales Market Share by Application in 2016
Table Middle East Therapeutic Nuclear Medicines Sales Volume (MT) by Countries (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Sales Volume Market Share by Countries in 2016
Table Middle East Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Israel Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure UAE Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Iran Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Type in 2016
Table Africa Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Volume (MT) by Countries (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Countries in 2016
Table Africa Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017)
Table Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016
Figure South Africa Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Table Cardinal Health Therapeutic Nuclear Medicines Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Mallkrodt Plc Therapeutic Nuclear Medicines Basic Information List
Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table GE Healthcare Therapeutic Nuclear Medicines Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Therapeutic Nuclear Medicines Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Basic Information List
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Nordion Therapeutic Nuclear Medicines Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Basic Information List
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure EMEA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top